Lim Soo-Jeong, Kim Chong-Kook
National Research Lab for Drug and Gene Delivery, College of Pharmacy, Researche Institute of Pharmaceutical Sciences, Seoul National University, San 56-1, Shinlim-Dong, Kwanak-Gu, Seoul 151-742, South Korea.
Int J Pharm. 2002 Aug 28;243(1-2):135-46. doi: 10.1016/s0378-5173(02)00269-7.
Solid lipid nanoparticles (SLNs) have gained attention as a colloidal drug carrier, particularly for drugs with limited solubility. The poor aqueous solubility of all-trans retinoic acid (ATRA) has been a limiting factor in its clinical use. This study was undertaken to overcome the solubility limitation of ATRA by loading in SLNs. The physicochemical characteristics of ATRA-loaded SLNs were investigated by particle size analysis, zeta potential measurement, thermal analysis and HPLC determination of ATRA content. The mean particle size of ATRA-loaded SLNs could be reduced (1) by mixing EggPC and Tween 80 as a surfactant and (2) by increasing the total surfactant amount. The smallest mean particle size of SLNs was obtained with 50 mg/g surfactant mixture composed of 54:46% (w/w) EggPC:Tween 80 (154.9 nm). The zeta potential of SLNs could be increased by mixing EggPC, Tween 80 and DSPE-PEG in the surfactant mixture. The zeta potential of SLNs prepared with 50 mg/g surfactant mixture composed of 48:6:46% (w/w) of EggPC:DSPE-PEG:Tween 80 was -38.18 mV. ATRA could be loaded at 2.4% (percentage of lipid matrix) on these SLNs without impairing their physical stability. After freeze-drying, the mean particle size and polydispersity index of ATRA-loaded SLNs were only slightly increased (181.8 vs. 265.2 nm, 0.173 vs. 0.200). Furthermore, no significant change was observed in the SLN-loaded concentration of ATRA and the zeta potential of SLNs after freeze-drying. Taken together, SLN formulation of ATRA with similar characteristics to those of parenteral emulsions could be obtained even after freeze-drying.
固体脂质纳米粒(SLNs)作为一种胶体药物载体已受到关注,特别是对于溶解度有限的药物。全反式维甲酸(ATRA)较差的水溶性一直是其临床应用的限制因素。本研究旨在通过将ATRA载入SLNs中来克服其溶解度限制。通过粒度分析、ζ电位测量、热分析和HPLC测定ATRA含量来研究载ATRA的SLNs的理化特性。载ATRA的SLNs的平均粒径可以通过以下方式减小:(1)将蛋黄卵磷脂(EggPC)和吐温80作为表面活性剂混合;(2)增加表面活性剂总量。由54:46%(w/w)的EggPC:吐温80组成的50 mg/g表面活性剂混合物制得的SLNs的最小平均粒径为154.9 nm。通过在表面活性剂混合物中混合EggPC、吐温80和二硬脂酰磷脂酰乙醇胺-聚乙二醇(DSPE-PEG),可以提高SLNs的ζ电位。由48:6:46%(w/w)的EggPC:DSPE-PEG:吐温80组成的50 mg/g表面活性剂混合物制备的SLNs的ζ电位为-38.18 mV。ATRA可以以2.4%(脂质基质百分比)载入这些SLNs中,而不损害其物理稳定性。冻干后,载ATRA的SLNs的平均粒径和多分散指数仅略有增加(分别为181.8对265.2 nm,0.173对0.20)。此外,冻干后载于SLNs中的ATRA浓度和SLNs的ζ电位均未观察到显著变化。综上所述,即使经过冻干,也可以获得具有与肠胃外乳剂相似特性的ATRA的SLN制剂。